Synthetic super-enhancers enable viral immunotherapy for glioblastoma
Información
Fecha: 10/06/2026
Hora 15:00
Lugar: Auditorio CNIO
Conferenciante Steven M. Pollard
Procedencia Professor of Stem Cell and Cancer Biology Co-Director of the CRUK Brain Tumour Centre of Excellence Associate Director CRUK Scotland Centre University of Edinburgh, UK
Invitado por Manuel Valiente, Brain Metastasis Group, Tumour Biology Programme, CNIO
Entrada libre hasta completar aforo
